Panelists discuss how Bruton tyrosine kinase (BTK) inhibitors have transformed the treatment paradigm for patients with chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL ...
Patient-Centered Selection of BTK Inhibitors: Balancing Clinical Factors and Patient Preferences EP: 16 . Implementation of Shared Decision-Making in BTK Inhibitor Treatment ...
来自MSN12 个月
Some lymphomas become resistant to treatment. Gene discovery may offer path to overcome it.BTK inhibitors, including the commonly used drug ibrutinib, block B cells' signaling pathway. This is helpful for treating B-cell lymphomas because the cancers arise when this signaling pathway ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果